Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds (2018)
- Authors:
- Autor USP: BARGIERI, DANIEL YOUSSEF - ICB
- Unidade: ICB
- DOI: 10.1128/AEM.00235-18
- Subjects: PARASITOLOGIA; PLASMODIUM; TRANSGENES; MALÁRIA; MEDICAMENTO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2018
- Source:
- Título do periódico: Antimicrobial Agents and Chemotherapy
- ISSN: 1098-6596
- Volume/Número/Paginação/Ano: v. 62, n. 11, p. e01053-18, 2018
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
CALIT, Juliana et al. Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds. Antimicrobial Agents and Chemotherapy, v. 62, n. 11, p. e01053-18, 2018Tradução . . Disponível em: https://doi.org/10.1128/AEM.00235-18. Acesso em: 03 jun. 2024. -
APA
Calit, J., Dobrescu, I., Gaitán, X. A., Borges, M. H., Ramos, M. S., Eastman, R. T., & Bargieri, D. Y. (2018). Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds. Antimicrobial Agents and Chemotherapy, 62( 11), e01053-18. doi:10.1128/AEM.00235-18 -
NLM
Calit J, Dobrescu I, Gaitán XA, Borges MH, Ramos MS, Eastman RT, Bargieri DY. Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 62( 11): e01053-18.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1128/AEM.00235-18 -
Vancouver
Calit J, Dobrescu I, Gaitán XA, Borges MH, Ramos MS, Eastman RT, Bargieri DY. Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 62( 11): e01053-18.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1128/AEM.00235-18 - Torin 2 derivative, NCATS-SM3710, has potent multistage antimalarial activity through inhibition of P. falciparum Phosphatidylinositol 4-Kinase (PfPI4KIIIβ)
- QSAR-driven design and discovery of novel compounds with antiplasmodial and transmission blocking activities
- Protection against COVID-19: beyond antibodies
- Invasão, transmissão e vacinas: estudos usando modelos de malária experimental
- Plasmodium Merozoite TRAP family protein is essential for vacuole membrane disruption and gamete egress from erythrocytes
- Toxoplasma gondii e toxoplasmose
- A arma secreta das universidades estaduais paulistas
- Integrative multi-kinase approach for the identification of potent antiplasmodial hts
- Quantas vidas vale um clique?
- Transcriptomics-Guided in silico drug repurposing: identifying new candidates with dual-stage antiplasmodial activity
Informações sobre o DOI: 10.1128/AEM.00235-18 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
